TP53 C-terminal alternative isoforms have abolished or severely decreased tumor suppressor activity, and therefore an increase in fraction of TP53 C-terminal alternative isoforms may be expected in tumors with wild type TP53. The gene discussed is TP53; the disease is neoplasm.